报价延迟最少15分钟:2024/05/08 19:22 EDT
|
|
|
|
|
||||||||||||
|
|
|
|
|
212.88 
|
|
|
| 价值评估 |
|
盈利(现时/预测)
6.04/8.46
|
|
企业价值
33.30B
|
| 资产负债 |
|
每股账面净值
31.52
|
| 现金流量 |
|
现金流量率
0.04
|
| 损益表 |
|
收益
4.22B
|
|
每股收益
29.78
|
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
报价延迟最少15分钟：2024/05/08 19:22 EDT
同行比较之报价最少15分钟延迟
|
业务概览
|
|||
| ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting. |